GSK, Vir Biotech to expand COVID-19 research partnership for other diseases
Posted by
www.biotecnika.org
As a part of the deal to research and develop monoclonal antibody
treatments for influenza and other respiratory illnesses, GSK will
make a further $120 million equity investment in Vir and an additional
upfront payment of $225 million.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gsk-vir-biotech-to-expand-covid-19-research-partnership-for-other-diseases/articleshow/81062795.cms
Subscribe to:
Post Comments (Atom)
October 8, 2021 at 1:39 AM
Mostly I do not comment on any post, but your blog has lots of knowledge about Custom Peptide Synthesis Services Online. It's forcing me to do this. It has really amazing content. Please share more information with us.
October 1, 2022 at 2:30 PM
Alas, not all students can think of the fact that in order to relax more just click here for more, and you can buy an assignment online from a reliable online writer and relax while writing a paper
June 22, 2023 at 8:17 PM
I appreciate the excellent material you published. I enjoy your description of the original content. Your concerns are both legitimate and logical.
June 29, 2023 at 7:03 PM
Although not very related, but I would like to introduce you to this game. let's relax.
Thank you!
March 4, 2024 at 11:18 PM
I find the information you give both interesting and helpful, so I read it often io games unblocked
Post a Comment